EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Superficial Conjunctival Cells from Dupilumab-Treated Patients with Atopic Dermatitis with Ocular Adverse Events Display a Transcriptomic Psoriasis Signature

Myriam Cassagne, Stéphane Galiacy, Anna Kychygina, Eric Chapotot, Martin Wallaert, Bertrand Vabres, Marie Tauber, Sébastien Barbarot, Carle Paul, Pierre Fournié, Michel Simon, FRench Atopic DErmatitis Network and the Groupe de Recherche sur l'Eczema Atopique

Journal of Investigative Dermatology · 2025

DOI: 10.1016/j.jid.2024.08.024 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Investigative Dermatology, 2025. Verfasst von Myriam Cassagne und 11 weiteren Autor:innen. Beteiligte Einrichtung: Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), INSERM, CNRS, Toulouse III Paul Sabatier University, Toulouse, France; Depart…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Antibodies, Monoclonal, Humanized, Psoriasis, Conjunctiva. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, Université de Toulouse, National Forestry and Grassland Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dupilumab has demonstrated efficacy in the treatment of atopic dermatitis. However, a subset of patients experiences ocular adverse events (OAEs), including conjunctivitis and dry eye syndrome, the pathological mechanisms of which are still unknown. In a bicentric study, we used DNA microarray analysis to compare the transcriptome of conjunctival cells of patients with atopic dermatitis collected by impression cytology before (M0) and 4 months after (M4) initiating dupilumab treatment. Thirty-six patients were included and divided in 2 groups according to their ophthalmological status at M4: 12 with OAEs (OAE+) and 24 without (OAE-). The analysis revealed 52 differentially expressed genes between OAE+ and OAE- patients at M0 and 113 at M4. Ingenuity Pathway Analysis enrichment revealed a psoriasis signature in OAE+ patients, both before and after OAE outcomes. In addition, we noticed the overexpression of several genes involved in keratinocyte differentiation, particularly encoding cornified envelope components. Among the 16 differentially expressed genes selected for real-time RT-PCR validation, 9 were confirmed as upregulated at M4 in OAE+ versus OAE- patients, validating the psoriasis signature, whereas MUC7 was downregulated. In conclusion, these results suggest that a conjunctival transcriptomic profile predisposes some patients with atopic dermatitis to developing OAEs upon dupilumab treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicAntibodies, Monoclonal, HumanizedPsoriasisConjunctivaTranscriptomeConjunctivitisDry Eye SyndromesHumansMaleFemaleAdultMiddle AgedGene Expression Profiling

Stichwörter der Autor:innen

Atopic dermatitisConjunctival impressionConjunctivitisDupilumabTranscriptomics

Substanzen

dupilumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), INSERM, CNRS, Toulouse III Paul Sabatier University, Toulouse, France; Department of Ophthalmology, Hôpital Purpan, University Hospital, Toulouse,…
  • Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), INSERM, CNRS, Toulouse III Paul Sabatier University, Toulouse, France.
  • Department of Ophthalmology, Hôpital Purpan, University Hospital, Toulouse, France.
  • Department of Ophthalmology, University Hospital, Nantes, France.
  • Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), INSERM, CNRS, Toulouse III Paul Sabatier University, Toulouse, France; Department of Dermatology, CHU Toulouse, Toulouse, France; Department of All…
  • Department of Dermatology, CHU Nantes, INRAE, UMR 1280, PhAN, Nantes University, Nantes, France.

Förderung

  • European Commission
  • Université de Toulouse
  • National Forestry and Grassland Administration
  • INSERM
  • Société Francophone du Diabète
  • Societe Francaise de Dermatologie et de Pathologie Sexuellement Transmissible
  • University of Toulouse 3
  • National Centre for Scientific Research

Zitieren

APA

Cassagne, M., Galiacy, S., Kychygina, A., Chapotot, E., Wallaert, M., Vabres, B., Tauber, M., Barbarot, S., Paul, C., Fournié, P., Simon, M., & FRench Atopic DErmatitis Network and the Groupe de Recherche sur l'Eczema Atopique (2025). Superficial Conjunctival Cells from Dupilumab-Treated Patients with Atopic Dermatitis with Ocular Adverse Events Display a Transcriptomic Psoriasis Signature. Journal of Investigative Dermatology. https://doi.org/10.1016/j.jid.2024.08.024

Vancouver

Cassagne M, Galiacy S, Kychygina A, Chapotot E, Wallaert M, Vabres B, et al. Superficial Conjunctival Cells from Dupilumab-Treated Patients with Atopic Dermatitis with Ocular Adverse Events Display a Transcriptomic Psoriasis Signature. Journal of Investigative Dermatology. 2025. doi:10.1016/j.jid.2024.08.024

BibTeX
@article{Cassagne2025,
  author = {Cassagne, Myriam and Galiacy, Stéphane and Kychygina, Anna and Chapotot, Eric and Wallaert, Martin and Vabres, Bertrand and Tauber, Marie and Barbarot, Sébastien and Paul, Carle and Fournié, Pierre and Simon, Michel and FRench Atopic DErmatitis Network and the Groupe de Recherche sur l'Eczema Atopique, FRench Atopic DErmatitis Network and the Groupe de Recherche sur l'Eczema Atopique},
  title = {Superficial Conjunctival Cells from Dupilumab-Treated Patients with Atopic Dermatitis with Ocular Adverse Events Display a Transcriptomic Psoriasis Signature},
  journal = {Journal of Investigative Dermatology},
  year = {2025},
  doi = {10.1016/j.jid.2024.08.024}
}
Kostenlos starten →